Early research (Phase 1)Study completedNCT00293488What this trial is testingSL-11047 in Treating Patients With Relapsed or Refractory LymphomaWho this might be right forLymphoma Progen Pharmaceuticals 20
Testing effectiveness (Phase 2)Looking for participantsNCT07249905What this trial is testingDose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of LymphomaWho this might be right forLymphomaWaldenström Macroglobulinemia (WM)DLBCL - Diffuse Large B Cell Lymphoma+5 more ModeX Therapeutics, An OPKO Health Company 180
Early research (Phase 1)Ended earlyNCT03886649What this trial is testingCopanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.Who this might be right forNon-Hodgkin Lymphoma Swiss Cancer Institute 7
Early research (Phase 1)Active Not RecruitingNCT05753501What this trial is testingStudy to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesWho this might be right forHematologic Cancer AbbVie 135
Not applicableStudy completedNCT00856388What this trial is testingFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more Roswell Park Cancer Institute 62
Early research (Phase 1)Ended earlyNCT03432741What this trial is testingDirect Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerWho this might be right forBreast AdenocarcinomaMetastatic Breast CarcinomaRecurrent Breast Carcinoma+11 more Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT00062296What this trial is testingEpirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Fox Chase Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT01177371What this trial is testingHigh-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more Case Comprehensive Cancer Center 13
Not applicableStudy completedNCT00098566What this trial is testingLong-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaQuality of Life Fred Hutchinson Cancer Center 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07713459What this trial is testingA Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomasWho this might be right forLymphoma NonhodgkinMarginal Zone B Cell LymphomaDiffuse Large B Cell Lymphoma (DLBCL)+2 more Kure Cells, INC 105
Testing effectiveness (Phase 2)Study completedNCT03144674What this trial is testingINCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)Who this might be right forLymphoma Incyte Corporation 110
Not applicableStudy completedNCT00445731What this trial is testingA Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forCancer University of Minnesota 115
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00453206What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Wake Forest University Health Sciences 66
Testing effectiveness (Phase 2)Study completedNCT01075321What this trial is testingEverolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+16 more Mayo Clinic 58
Early research (Phase 1)Ended earlyNCT02914938What this trial is testingME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's LymphomaWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Follicular Lymphoma (FL)+4 more MEI Pharma, Inc. 97
Early research (Phase 1)Looking for participantsNCT06340737What this trial is testingAutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell LymphomasWho this might be right forFollicular LymphomaMantle Cell LymphomaHairy Cell Leukemia+5 more Stanford University 148
Testing effectiveness (Phase 2)Study completedNCT01647971What this trial is testingStudy of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forNon-Hodgkins LymphomaB-cell LymphomaWaldenstrom's Macroglobulinemia+4 more TG Therapeutics, Inc. 39
Early research (Phase 1)Study completedNCT00004258What this trial is testingEMD 121974 in Treating Patients With Locally Advanced or Metastatic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Indiana University 40
Early research (Phase 1)Ended earlyNCT02168907What this trial is testingCPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic LeukemiaCutaneous B-cell Non-Hodgkin Lymphoma+24 more Wake Forest University Health Sciences 1